IGHE and allergic disease: GRADE 2 was adverse symptoms, together with the evidence of biomarkers, such as sensitization identified by SPT or sIgE; GRADE 3 came from the data about self-reported results alone, as well as only evidence of IgE data to identify food allergy, and patients with allergy were identified by retrospective review of medical records.